Sleep-disordered breathing (SDB) is a common disorder that affects approximately 50% of men and 23% of women aged between 40 and 85 years [1] . Previous studies observed a high prevalence of SDB in patients with coronary artery disease undergoing coronary artery bypass grafting (CABG) surgery [2] [3] [4] . About 46% of patients with chronic heart failure are reported to have SDB, of whom approximately 50% are diagnosed with central sleep apnea (CSA) and 50% with obstructive sleep apnea (OSA) [5, 6] .
Coronary artery bypass grafting is the most frequently conducted cardiac surgery worldwide, and is performed approximately 50,000 times in Germany every year [7] . Despite major advances in surgery, patients undergoing CABG are still at a substantial risk of developing cardiac, respiratory, and cerebrovascular complications [7] .
Patients with SDB are more prone to developing cardiac complications, such as arrhythmia, myocardial infarction, the need for revascularization procedures, and cardiac arrest [3, 8] . Moreover, SDB is associated with a higher rate of respiratory complications such as pneumonia or acute respiratory distress syndrome (ARDS), as well as with prolonged intubation and mechanical ventilation [9] [10] [11] [12] . Furthermore, the occurrence of postoperative delirium is higher in patients with SDB than in patients without SDB [13] . In a retrospective analysis of 100 patients undergoing elective CABG surgery, we could recently show that SDB-particularly OSA-was associated with a prolonged postoperative hospital stay, independent of known confounders [4] .
Sa far, few prospective observational studies have addressed peri-and postoperative complications in patients with SDB undergoing cardiac surgery. Previous studies were limited by relatively small study populations and the fact that the severity and type of SDB were not taken into account [3, [13] [14] [15] [16] . Because most studies did not include a multivariable regression analysis, the influence of potential confounders remains unclear [10, 14] . Furthermore, long-term follow-up data are sparse.
The objectives of the present observational study are to evaluate the impact of SDB on the rate of major adverse cardiac and cerebrovascular events (MACCE) in patients undergoing elective CABG surgery. In addition, explorative analyses will allow specification of subgroups of patients with SDB with the highest risk for peri-and postoperative complications. The results of this study may contribute to designing interventional studies and to optimizing the preoperative risk assessment as well as the peri-and postoperative management of patients with and without SDB undergoing elective cardiac surgery. Moreover, the biomaterial sub-study may generate novel hypotheses and improve diagnosis and management of atrial fibrillation in SDB patients.
Methods

Study patients
The current prospective observational study, "Impactofsleep-disordered breathing on atrial fibrillation and perioperative complications in patients undergoing coronary artery bypass grafting surgery (CONSIDER AF), " is a single-center study designed to evaluate the impact of Recruitment was started in July 2016 and enrolment is expected to be completed in July 2021. As the duration of follow-up for each patient will be 2 years, data analysis will be finished by July 2023 and a final report will be available at the beginning of 2024. In advance, selected research questions may be analyzed in a purely exploratory manner, provided that data management is conducted according to the data handling plan described in the online supplement. In brief, the project proposal and statistical analysis plan need to be submitted to the steering committee for approval before any data analysis is performed.
Standard clinical treatment
Patients do not routinely receive any premedication prior to surgery . Induction and maintenance of anesthesia are at the discretion of the anesthesiologists. All patients receive postoperative treatment according to the fast-track recovery care protocol that aims at early extubation and prompt implementation of mobility and occupational therapy within the intensive (ICU) and intermediate care unit (IMC) settings [17, 18] . Patients are weaned from mechanical ventilation at the discretion of the ICU physicians. Recommended delirium-prevention strategies are implemented within the standard postoperative care of patients [19, 20] .
Study objectives
The aim of the prospective observational study CONSIDER AF is to determine whether the rate of MACCE is higher and the occurrence of atrial fibrillation and perioperative complications more frequent in patients with SDB undergoing elective CABG surgery compared to those without SDB. Primary and secondary objectives as well as the objectives of the accompanying biomaterial study are presented in . Table 2 .
Assessment of sleep-disordered breathing
After enrolment into the study, SDB monitoring is performed during the night before CABG surgery. Nasal flow, pulse oximetry, and thoracic breathing effort are measured with the Alice NightOne device (Philips Respironics, Murrysville, PA, USA). As described previously [4] , apnea is defined as a ≥ 80% decrease in airflow for ≥10 s, hypopnea as a decrease in airflow by ≥50-80% versus baseline for ≥10 s, and desaturationas a ≥ 4% decrease in oxygen saturation. The apnea-hypopnea index (AHI) is expressed as the frequency of apneas or hypopneas per hour of sleep, and an AHI of ≥15/h is considered the cut-off for the diagnosis of SDB. Patients with SDB and ≥50% central apneas are classified into the CSA group and patients with <50% central apneas into the OSA group.
By means of structured phone interviews at visits 4, 5, and 6, the use of mandibular advancement devices, longterm oxygen therapy, or positive airway pressure treatment is assessed. Details on recommendation and prescription of SDB therapies as well as treatment adherence are systematically examined.
Postoperative outcomes
MACCE and coronary revascularization procedures
Primary endpoint is the first occurrence of any component of the composite endpoint MACCE including all-cause mortality, non-fatal myocardial infarction (MI), and non-fatal cerebrovascular event occurring during or after CABG surgery within a) 60 days (visits 2 to 4), b) 1 year (visit 5), and c) 2 years (visit 6) of CABG surgery. All-cause mortality is defined as occurrence of death from any cause.
Periprocedural MI (early, within 72 h of CABG) or late MI (>72 h after CABG) are defined in accordance with the up-defined as an apnea-hypopnea index ≥15/h. Biomaterials (atrial myocardium and blood cells) are systematically sampled. New-onset atrial fibrillation and peri-and postoperative complications are prospectively evaluated during the hospital stay and over a period of 2 years. The relationship between postoperative complications and SDB or covariables associated with postoperative complications in univariable analyses are determined by multivariable logistic regression. Moreover, length of hospital stay and time spent in the intensive/intermediate care unit (ICU/IMC) of patients with and without SDB are analyzed. The harvested biomaterials are analyzed for novel signaling events and biomarkers.
Discussion. The prospective observational CONSIDER AF study is needed to identify specific risks, including SDB, and risk populations in cardiac surgery. In addition, CONSIDER AF has the potential to generate the rationale for hypotheses regarding periand postoperative management of patients with SDB to be tested in future randomized clinical trials. Based on this knowledge, the peri-and postoperative management of patients with SDB may be optimized. To ascertain the above endpoints, quantitative measurement of TnI, creatine kinase (CK), and CK-muscle/brain (CK-MB) fraction as well as electrocardiograms and cerebral imaging reports are analyzed in a blinded manner by the clinical events committee. This process insures that events critical to the analysis of the study will be assessed in a uniform manner.
Keywords
Postoperative atrial fibrillation
New-onset atrial fibrillation as detected within the postoperative phase is assessed by routine 24 h ECG monitoring. During the in-hospital phase after CABG surgery, initiation of pharmacologic therapy and electric cardioversion as well as anticoagulation therapy for treatment of atrial fibrillation is obtained from clinical records. At 60 days, 1 year, and 2 years after CABG surgery, assessment of pharmacologic therapy, cardioversion, and anticoagulation therapy for the treatment of atrial fibrillation is part of the structured phone interview. Medication for rhythm control of atrial fibrillation is recorded according to the Vaughan-Williams classification.
Moreover, the validated Atrial Fibrillation Effects on Quality of Life (AFEQT) questionnaire is provided for patients who are diagnosed with atrial fibrillation as part of the follow-up visits 60 days, 1 year, and 2 years after CABG surgery. Permission to use the AFEQT questionnaire was granted by the copyright holders. The AFEQT is a 20-item survey using 7-point response scales, which measures atrial fibrillation-specific health status [23] . It quantifies four domains of patients' health status: symptoms, daily activities, treatment concern, and treatment satisfaction. The AFEQT scores range from 0 to 100, with 100 representing the best possible health status and 0 representing the worst.
Within a subset of the CONSIDER AF population, continuous ECG monitoring with an automated atrial fibrillation detection algorithm is performed to detect atrial fibrillation in the earlyphase (1-7 days) post CABG. Patients are instructed to wear the monitor as much as possible for 7 days. All the episodes of atrial fibrillation are adjudicated by two cardiologists who are unaware of the patient's demographic and clinical characteristics, and any disagreements are resolved by discussion with an independent cardiologist. Results are sent to the family physician of the patient, and decisions regarding anticoagulant therapy are made at the discretion of the treating physicians.
Major pulmonary and respiratory complications
Endotracheal intubation is rated as difficult in the presence of poor visualization of the glottis (Cormack and Lehane grade III or IV), when an intubation aid (stylet, intubating laryngeal mask airway, fiberoptic bronchoscope) is needed, or when three or more intubation attempts are required [24] . Peri-and postoperative hypoxemia is considered present if the patient develops oxygen desaturations < 90% for or with a ≥ 4% reduction from the last recorded preoperative value. Postoperative respiratory failure is defined as a need for prolonged mechanical ventilation for ≥24h or a need for endotracheal reintubation or tracheostomy [10] . ARDS, pneumonia, or pulmonary embolism represent major pulmonary complications. Diagnosis of ARDS is made according to the Berlin Definition [25] by an acute onset within 1 week of CABG, bilateral opacities on chest imaging, an PaO2/FiO2 < 300 mm Hg, To determine whether the rate of postoperative atrial fibrillation is higher in patients with SDB within 60 days, 1 year, and 2 years after CABG surgery compared to those without SDB.
To determine whether the occurrence of postoperative stroke is more frequent in patients with SDB within 60 days, 1 year, and 2 years after CABG surgery compared to those without SDB.
To determine whether SDB patients have a higher rate of MACCE within 60 days, 1 year, and 2 years after CABG surgery compared to those without SDB.
To determine whether SDB patients have a higher rate of major pulmonary complications within 60 days, 1 year, and 2 years (including pneumonia, respiratory insufficiency, and pulmonary embolism) after CABG surgery compared to those without SDB.
To determine whether the rate of peri-and postoperative respiratory complications (difficult intubation, hypoxemia, respiratory failure, use of extracorporeal mechanical oxygenation device) is higher in patients with SDB compared to those without SDB.
To determine whether the rate of peri-and postoperative hemodynamic instability and heart failure is higher in patients with SDB compared to those without SDB.
To determine whether the rate of postoperative enzymatic myocardial injury is higher in patients with SDB compared to those without SDB.
To determine whether the rate of postoperative acute kidney injury is higher in patients with SDB compared to those without SDB.
To determine whether the rate of postoperative delirium is higher in patients with SDB compared to those without SDB.
To determine whether patients with SDB have an impaired general (EuroQol, Atrial Fibrillation Effect on Quality of Life, Seattle Angina Questionnaire) and disease-specific quality of life compared to those without SDB
Objective of the biomaterial study
To determine key signaling events in atrial myocardium that may predispose to atrial fibrillation 
Hemodynamic instability and acute heart failure
Hemodynamic instability due to any cause is defined as a need for vasopressors or inotropes (epinephrine, norepinephrine, dobutamine, and milrinone) for ≥48 h postoperatively. Postoperative acute heart failure is defined as new pulmonary edema, increased of use of diuretic or afterload/preload reducing agents, or physician's documentation of acute heart failure. Postoperative use of circulatory assist devices is recorded.
Postoperative enzymatic myocardial injury and coronary revascularization procedures
Evaluation of perioperative enzymatic myocardial injury, as measured by the perioperative release of TnI and CK-MB, is performed by analysis of serial blood samples. These markers have been found to be predictive of major cardiac events after CABG surgery [26, 27] . Serial blood samples are drawn on admission (1) to the surgical ICU and at 4-10 (2) and 14-24 (3) hours after surgery according to clinical routine. Levels of serum TnI are measured with luminescence oxygen channeling immunoassay. The highest TnI value during the first 24h was taken as peak TnI. At visits 3 to 6, coronary revascularization procedures are assessed and ascertained by the Clinical Events Committee using the patients' clinical records and medical reports.
Postoperative acute kidney injury
Postoperative acute kidney injury (AKI) is defined according to the Kidney Disease Improving Global Outcomes (KDIGO) Foundation guideline [28] . As KDIGO recommends staging AKI according to its severity, stage 1 is defined as increased serum creatinine ≥1.5 to 1.9 times the baseline value or ≥0.3 mg/dl from baseline or urine output <0.5 ml/kg per hour for 6-12 h; stage 2 is defined as increased serum creatinine ≥2.0 to 2.9 times the baseline value or urine output <0.5 ml/kg per hour for 12 h; and stage 3 is defined as increased serum creatinine ≥3 the baseline value or ≥4 mg/dl or initiation of renal replacement therapy, or urine output <0.3 ml/kg per hour for 24 h or anuria for 12 h [28] . The need for renal replacement therapy is specified as temporary or permanent (in case the patient dies or is discharged on renal replacement therapy).
Assessment of postoperative delirium
Delirium is assessed once a day using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) [29] . The CAM-ICU is a valid and reliable delirium assessment tool that has shown high sensitivity (93%) and specificity (89%) for the diagnosis of delirium [30] and is recommended by the American College of Critical Care Medicine [31] . The CAM-ICU scores are obtained by trained medical staff on the day of extubation and for a maximum of 3 days. Before CAM-ICU assessment, the sedative state is evaluated as a standard feature using the Richmond Agitation and Sedation Scale (RASS) [32, 33] . In patients with deep sedative stages, rated as a RASS score of -4 or -5, evaluation is omitted.
Assessment of quality of life
In order to assess general and diseasespecific quality of life, the validated and self-administered questionnaires EuroQuol 5D (EQ-5D) and Seattle Angina questionnaire (SAQ) are distributed by mail as part of the follow-up visits 60 days, 1 year, and 2 years after CABG surgery. Permissions to use the EQ-5D and SAQ questionnaires were obtained from the copyright holders. The EQ-5D questionnaire has five dimensions focusing on mobility, selfcare, usual activities, pain/discomfort, and anxiety/depression [34] . Each dimension has three levels: no problems (no limitations), some problems, and severe problems. Furthermore, general health status is measured on a visual analog scale (VAS) in which 0 denotes the worst imaginable health state and 100 the best imaginable health state.
The SAQ is a 19-item questionnaire measuring five dimensions of health status: exertional capacity, anginal stability, anginal frequency, treatmentsatisfaction, and quality of life, generating five independent scales [35] . Each question is measured on an ordinal scale from 1 to 5 (6 for the angina frequency scale), with 1 indicating the lowest/poorest response and 5/6 indicating the highest/best response.
Biomaterial sampling
Right atrial appendage biopsies are received from patients during elective CABG [36] . Biopsies are transported in ice-cold Custodiol ® (Essential Pharmaceuticals, LLC, Durham, NC, USA) solution containing 2 mmol/L butanedione monoxime (BDM) for cardioplegia to our laboratories. Upon arrival, human biopsies are immediately frozen and stored in a tissue biobank at -80°C. Tissue is used for measurement of protein or gene expression by western blotting or PCR, respectively. Besides tissue samples, blood samples are taken from the patients immediately before surgery and used for isolation of peripheral blood mononuclear cells (PBMCs). The PBMCs are rapidly frozen and stored in a liquid biobank at -80°C. The remaining blood plasma is also collected and stored separately in the liquid biobank. It is planned to analyze PMBCs for gene expression by PCR or fluorescence-activated cell scanning (FACs). Plasma samples are analyzed for the presence of oxidized low-density lipoproteins. For some experiments, atrial biopsies are also used immediately for assessment of contractile function, arrhythmias, intracellular Ca and Na ion handling, and whole-cell patch clamp electrophysiology (ion currents and membrane potential). Briefly, human atrial trabeculae are microdissected and mounted onto a force transducer in an organ bath. Contraction is elicited by electrical field stimulation and the developed mechanical force is recorded. Besides contractility measurements, premature atrial contractions (PACs) are analyzed as a surrogate for atrial arrhythmias. In separate experiments, human atrial cardiomyocytes are isolated from tissue by chunk isolation [36] . Isolated atrial cardiomyocytes are plated onto laminincoated measurement chambers, loaded with fluorescence dyes for assessment of intracellular Ca (Fluo-4, 10 μmol/L) or Na (SBFI, 10 μmol/L), and mounted on the stage of either epifluorescence microscopes (IonOptix Limited, Dublin, Ireland) or a confocal microscope (Zeiss LSM 700; Zeiss, Oberkochen, Germany). Some cardiomyocytes are used for measurement of sarcolemmal ion currents and membrane potential by whole-cell patch clamp (HEKA Elektronik Dr. Schulze GmbH, Lambrecht/ Pfalz, Germany).
Statistical analysis
Statistical analyses will be performed using SPSS software version 24.0 or higher (IBM SPSS Statistics, Armonk, New York, USA). Data will be described as mean and standard deviation for normally distributed data, as median (25th;75th percentile) for non-normally distributed data, and as numbers and percentages for categorical variables. The normality of data distribution will be determined using the Kolmogorov-Smirnov test. Differences in baseline characteristics, nocturnal respiration data, and outcome variables between patients with and without SDB (analysis population I) or patients with different severities and types of SDB (analysis populations II and III) will be compared using analysis of variance (ANOVA) for normally distributed continuous variables, the Kruskal-Wallis test for nonnormally distributed continuous variables and the Persons chi-square test for categorical variables. A two-sided p value of ≤0.05 will be considered statistically significant for all analyses.
Primary endpoint. A multivariable logistic regression model with the primary target variable MACCE within 60 days after CABG (no/yes) as the dependent variable and SDB (no/yes), age, body mass index (BMI), sex (male/female), heart failure (no/yes), and diabetes mellitus (no/yes) as independent variables will be carried out in order to test the null hypothesis H0: ORSDB = 1 (i. e., there is no difference between patients with SDB and without SDB regarding MACCE) at a two-sided 5% significance level. For the odds ratio (OR), a point estimate and a two-sided 95% confidence interval will be provided.
Secondary endpoints.
The risk of patients without SDB and with untreated and treated SDB for long-term outcomes such as the rate of MACCE will be calculated using multivariable Cox proportional hazard analysis. All secondary endpoints will be analyzed in a purely exploratory manner and summarized by means of descriptive statistics. Thus, p values and corresponding confidence intervals are descriptive in nature. Safety variables will be analyzed descriptively.
Sample size calculation
Sample size was calculated by means of the primary endpoint, i. e., MACCE within 60 days after CABG. The MACCE rate within 60 days is assumed to be 7% in the no SDB and 13% in the SDB group according to a recently published study by Uchoa et al. [3] These estimates result in an odds ratio (OR) of 1.99, which can be considered as highly clinically relevant. In a retrospective pilot data analysis, the prevalence of SDB (AHI ≥15/h) was 37%. Alpha (two-sided) was set to 0.05 and beta was set to 0.80 (power 80%).
To detect an odds ratio of 1.99 (patients with SDB vs. patients without SDB) with a prevalence of SDB of 37% with 80% power at a two-sided significance level of 0.05, a total of 815 patients are required. This calculation is based on a simple method of sample size calculation for logistic regression proposed by Hsieh et al. [37] . Since we expect confounding of the results by the covariates age, BMI, sex, heart failure, and diabetes mellitus, the primary analysis will be done using a multivariable logistic regression model. This may inflate the variance of the estimated parameter and thus reduce the power to detect the estimated effect. Therefore, the sample size will be adjusted by a conservative approach, dividing the sample size by the variance inflation factor (VIF) defined as 1-R 2 , where R 2 is the squared multiple correlation coefficient of the primary variable with the other covariates. The squared multiple correlation coefficient R 2 of AHI versus the other covariates was estimated to be 0.2 in our retrospective pilot data. Hence, the final sample size is n = 815/(1-0.2) = 1019 for fitting a multivariable logistic regression model. The sample size was calculated using R 3.2.1 (R Foundation for Statistical Computing, Vienna, Austria; http://www.R-project. org/).
According to a pilot analysis, we anticipate the failure rate to record a valid polygraphy to be 6% (n = 72) and the lostto-follow-up rate to assess the primary endpoint MACCE at 60 days to be 8% (n = 96). Thus, 1200 participants have to be enrolled in the study in order to include 1019 participants in the analysis.
Ethics and monitoring
Approval for this prospective observational study was granted by the Ethics Committees of the University of Regensburg (no. 15-101-0238). The study is conducted within the principles of Good Clinical Practice and in accordance with the Declaration of Helsinki.
Results
By October 2018, a total of 366 patients had been recruited into the ongoing CONSIDER AF study. Of these patients, 31 were excluded, preponderantly due to withdrawal of consent or same-day cancellation of CABG surgery. As their SDB monitoring was insufficient, 42 patients were omitted from the analysis. To date, the final CONSIDER AF analysis cohort consists of 293 patients who can be classified according to the presence and type of SBD (. Fig. 2 ).
Discussion
Inrecentyears, SDB hasbeenincreasingly recognized as an independent risk factor for the development of postoperative complications and a prolonged length of hospital stay after cardiac surgery. The prospective observational study CON-SIDER AF may extend previous research
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in a number of ways (. Table 3 ): firstly, a very large patient cohort as targeted in CONSIDER AF will provide robust analyses of perioperative complications in patients with SDB undergoing elective CABG surgery compared to those without SDB. Secondly, CONSIDER AF aims at investigating postoperative outcome in patients undergoing elective CABG surgery with and without SDB in a comprehensive manner, comprising cardiac, respiratory, and renal complications, as well as length of hospital stay. Long-term follow-up will monitor patients for a period of 2 years following elective CABG surgery. Thirdly, new-onset postoperative atrial fibrillation is detected by continuous ECG monitoring within a subset of patients and atrial fibrillation-associated symptoms and complications are systematically assessed during long-term follow-up. Potential pathogenetic mechanisms of postoperative atrial fibrillation at the cellular and multicellular level are expansively studied using human biomaterial (right atrial appendage biopsies, blood samples). Moreover, potential myocardial mechanisms will also be investigated in patient-specific PBMCs. The latter may be important to identify potential biomarkers that are suitable for clinical assessment in patient cohorts for which no atrial biopsies are available. Finally, in contrast to previous studies, the type and severity of SDB are preoperatively assessed using SDB monitoring, which offers a more thorough understanding of the potentially differential impact of OSA and CSA on adverse outcome.
Sample size
Previous studies on adverse outcome in patients with SDB undergoing cardiac surgery are limited by relatively small study populations comprising less than 250 patients (. Table 3 ; [3, 4, 11, [13] [14] [15] 38] . However, in order to analyze SDB as a potential modulator of new-onset atrial fibrillation and peri-and postoperative complications using multivariable regression models, a large patient cohort with a sufficient number of SDB cases is required. Since the present prospective observational study CONSIDER AF aims at enrolling 1200 patients, interpretation of the association between SDB and periand postoperative complications can be done in a meaningful way.
Assessment of postoperative outcomes
Recently, diagnosis of SDB with an AHI of ≥15/h was shown to be independently associated with length of hospital stay, prolonging hospitalization by 4 days in patients with OSA compared to patients without SDB [4] . This finding was consistent with a previous study by Bhama et al. [15] , in which the diagnosis of OSA significantly increased length of hospital stay after CABG from 13 to 24 days. Moreover, patients with SDB had a higher incidence of postoperative hemodynamic instability [4] , a higher incidence of MACCE, and were more prone to repeated revascularization procedures and typical angina [3] . Patients with SDB needed mechanical ventilation longer than patients without SDB [4, 14, 15] and were more likely to develop respiratory complications, e. g., pneumonia or acute respiratory distress syndrome [9] . Patients with SDB are more prone to developing cardiac complications, such as arrhythmia, myocardial infarction, the need for revascularization procedures, and cardiac arrest [3, 8] . Moreover, SDB is associated with a higher rate of respiratory complications such as pneumonia or ARDS as well as with prolonged intubation and mechanical ventilation [9] [10] [11] [12] . Furthermore, the occurrence of postoperative delirium is higher in patients with SDB than in patients without SDB [10, 13] .
While previous studies only focused on certain postoperative complications (. Table 3 ), CONSIDER AF covers a wide range of outcome parameters and aims at analyzing the impact of SDB on postoperative complications in a comprehensive manner. Moreover, not only short-term, but also long-term complications over a period of 2 years are investigated.
Assessment of postoperative atrial fibrillation
The present study will extend previous findings by evaluating the incidence of new-onset postoperative atrial fibrillation after elective CABG surgery in a sizable patient cohort with and without SDB. In a small-scale study by Uchôa et al. addressing the impact of OSA on new cardiovascular events in patients undergoing CABG surgery, newly diagnosed atrial fibrillation was more common in patients with than without OSA (22 vs. 0%, p < 0.01) in long-term follow-up [3] . This association between atrial fibrillation and OSA may be related to common risk factors and a mutually perpetuating pathophysiologic relationship between these conditions. Besides this, OSA promotes atrial fibrillation via electric and structural atrial remodeling [39] .
In the present study, new-onset atrial fibrillation as detected within the postoperative clinical routine and its standard treatment are systematically assessed. Unlike in previous studies, continuous ECG monitoring is performed within a subset of the CONSIDER AF population to detect subclinical events of atrial fibrillation. Symptoms and severe complications arising from atrial fibrillation, e. g., stroke or TIA, are evaluated in the long-term follow-up. Moreover, a unique and distinguishing feature of our prospective observational study is the systematic sampling of human biomaterials (right atrial appendage biopsies and blood samples) that allow further assessment of potential pathogenetic mechanisms of postoperative atrial fibrillation at the cellular and multicellular level. The latter could also lead to identification of novel blood biomarkers which may improve SDB diagnostics and help identify patients at risk of atrial arrhythmias.
Assessment of SDB and its subtypes
As a major limitation of previous studies addressing postoperative complications in patients with SDB undergoing cardiac surgery, there is little information available on the adverse impact of CSA on patients' outcome. However, a significant proportion of CABG patients must be assumed to have CSA, as one third of these patients suffer from heart failure with a reduced ejection fraction [40] and prevalence estimates for CSA among patients with chronic heart failure vary between 30 and 50% [41] . Therefore, our study will complement previous research by differentiating between OSA and CSA and thus offer a more comprehensive assessment of SDB and its subtypes on postoperative outcome. Though polysomnography is considered the gold standard for diagnosing SDB, portable SDB monitoring is used in this study. Consistent with routine clinical practice, the type of SDB is assessed by the frequency of obstructive and central apneas per hour of sleep. As measurements of nasal flow, pulse oximetry, and thoracic breathing effortare methodologically similar in portable SDB monitoring and polysomnography, there is no major difference in the discrimination between obstructive and central apneas.
For a more precise discrimination between OSA and CSA, hypopneas need to be classified into their obstructive and central nature [42] [43] [44] . This is not feasible with portable SDB monitoring, since sleep stages are not assessed by electroencephalography and an abdominal effort band and a snore microphone are not available to detect paradoxical breathing and snoring. Moreover, total sleep time is not measured during portable SDB monitoring.
To ensure a consistently high quality of SDB monitoring and low failure rates, the portable SDB monitoring device and its sensors are attached to the patient by trained medical staff. The quality of the SDB monitoring is considered adequate with at least 4 h of acceptable scored recordings that include pulse oximetry, nasal flow, and thoracic breathing effort. Hence, for feasibility reasons within our sizable patient cohort undergoing cardiac surgery the following day, the Alice NightOne devices represented a valid alternative to polysomnography.
Conclusion and perspectives
The present prospective observational study is needed to identify specific risks and risk populations in cardiac surgery. Data gathered by the CONSIDER AF study may facilitate identification of patients at a high-risk for an adverse outcome after cardiac surgery and contribute to the body of knowledge in the area of postoperative complications and SDB. In addition, CONSIDER AF has the potential to generate rational hypotheses regarding the peri-and postoperative management of patients with SDB to be tested in future randomized clinical trials. Based on this knowledge, the peri-and postoperative management of patients with SDB may be optimized to further minimize the rate of postoperative complications.
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